SAB BIOTHERAPEUTICS, INC. (SABSW) Operating margin 2020–2024
SAB BIOTHERAPEUTICS, INC. (SABSW) operating margin by fiscal year — reported operating income divided by reported revenue.
-3244.9%FY2024 · since FY2020: 37.2% → -3244.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -3244.9% | -1544.3 pp |
| FY2023 | -1700.6% | -1579.6 pp |
| FY2022 | -121.0% | -99.0 pp |
| FY2021 | -22.0% | -59.2 pp |
| FY2020 | 37.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice